Cetuximab Plus Combination Chemotherapy in Treating Patients With Stage IV Colorectal Cancer

NCT00020917 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators